NKF K/DOQI GUIDELINES
Executive Summaries of 2000 Updates
| Anemia | Hemodialysis | Peritoneal DialysisVascular Access | Nutrition | Chronic Kidney Disease | History of DOQI
|
|
NKF K/DOQI GUIDELINES Executive Summaries of 2000 Updates | Anemia | Hemodialysis | Peritoneal DialysisVascular Access | Nutrition | Chronic Kidney Disease | History of DOQI |
K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
Acronyms and Abbreviations
Grading Rationale Statements |
|
| Grade | Level of Evidence |
| S | Analysis of individual patient data from a single large, generalizable study of high methological quality (for example NHANES III) |
| C | Compilation of original articles (evidence tables) |
| R | Review of reviews and selected original articles |
| O | Opinion |
| AASK | African American Study of Kidney Disease and Hypertension | |
| ABPM | Ambulatory blood pressure monitoring | |
| ACE-inhibitor | Angiotensin converting enzyme inhibitor | |
| ADA | American Diabetes Association | |
| AFT | Autonomic function testing | |
| Alb | Albumin | |
| ASCVD | Atherosclerotic cardiovascular disease | |
| ASN | American Society of Nephrology | |
| AST | American Society of Transplantation | |
| ASTP | American Society of Transplant Physicians | |
| AV | Arterio-venous | |
| BAP | Bone alkaline phosphatase | |
| BDI | Beck Depression Inventory | |
| BEE | Basal energy expenditure | |
| BMI | Body mass index | |
| BP | Blood pressure | |
| BPI | Blood pressure index | |
| BSA | Body surface area | |
| BUN | Blood urea nitrogen | |
| CAD | Coronary artery disease | |
| CCD | Clinical cardiovascular disease | |
| CCr | Creatinine clearance | |
| CDI | Cognitive Depression Index | |
| CES-D | Center for Epidemiological Studies-Depression | |
| CG equation | Cockcroft-Gault equation | |
| CHD | Coronary heart disease | |
| CHF | Congestive heart failure | |
| Cin | Inulin clearance | |
| CKD | Chronic kidney disease | |
| COOP | Dartmouth COOP Clinical Improvement System | |
| COX 2 | Cyclo-oxygenase type 2 | |
| CPG | Clinical practice guideline | |
| CPM | Clinical performance measure | |
| CQI | Continuous quality improvement programs | |
| Cr | Creatinine | |
| CRF | Chronic renal failure | |
| CT | Computed tomography | |
| CTSCr | Clearance of creatinine due to tubular secretion | |
| CUrea | Urea clearance | |
| CVD | Cardiovascular disease | |
| D | Day(s) | |
| DBP | Diastolic blood pressure | |
| DCCT | Diabetes Control and Complications Trial | |
| DEI | Dietary energy intake | |
| DEXA | Dual energy x-ray absorptiometry (bone densitometry) | |
| DM | Diabetes mellitus | |
| DM I | Type 1 diabetes mellitus | |
| DM II | Type 2 diabetes mellitus | |
| DMMS | Dialysis Morbidity and Mortality Study | |
| DMSA | Dimercaptosuccinic acid | |
| DOQI | Dialysis Outcomes Quality Initiative | |
| DPI | Dietary protein intake | |
| DTPA | Diethylene triamine pentaacetic acid | |
| DUKE | Duke Health Profile | |
| DUSOI | Duke Severity of Illness | |
| ECr | Extra-renal creatinine elimination rate | |
| EDTA | Ethylene diamine tetraacetic acid | |
| EDX | Electrodiagnosis | |
| EEG | Electroencephalogram | |
| EMG | Electromyography | |
| ESRD | End-stage renal disease | |
| Exp | Exponent | |
| FSGS | Focal segmental glomerulosclerosis | |
| GCr | Creatinine generation rate | |
| GFR | Glomerular filtration rate | |
| GN | Glomerulonephritis | |
| HBP | High blood pressure | |
| HCFA | Health Care Financing Administration (currently Centers for Medicare and Medicaid Services, CMS) |
|
| HD | Hemodialysis | |
| HDFP | Hypertension Detection and Follow-Up Program | |
| HDL | High density lipoprotein | |
| Hgb | Hemoglobin | |
| HI | Health Index | |
| HIV | Human immunodeficiency virus | |
| HLA | Human leukocyte antigen | |
| HOPE | Heart Outcomes Prevention Evaluation | |
| HOT | Hypertension Optimal Trial | |
| Hr | Hour(s) | |
| HR | Heart rate | |
| HTN | Hypertension | |
| ICD-9 | International Classification of Diseases, 9th revision | |
| ICTP | Type I collagen cross linked telopeptides | |
| IDDM | Insulin dependent diabetes mellitus | |
| IDNT | Irbesartan in Diabetic Nephropathy Trial | |
| IEQ | Illness Effects Questionnaire | |
| IHD | Ischemic heart disease | |
| IN | Interstitial nephritis | |
| IOM | Institute of Medicine | |
| IPTH | Intact parathyroid hormone | |
| IRMA | Intraretinal microvascular abnormalities | |
| IVP | Intravenous pyelography | |
| JNC-VI | Sixth report of the Joint National
Committee for the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure |
|
| K/DOQI | Kidney Disease Outcomes Quality Initiative | |
| KDQOL | Kidney Disease Quality of Life | |
| KPS | Karnofsky Performance Scale | |
| Krt/Vurea | Renal urea clearance divided by volume of distribution | |
| Kt/Vurea | Urea clearance divided by volume of distribution | |
| LDL | Low density lipoprotein | |
| LMW | Low molecular weight | |
| LV | Left ventricle | |
| LVH | Left ventricular hypertrophy | |
| MAG3 | Mercaptoacetyltriglycine | |
| MAP | Mean arterial pressure | |
| Max | Maximum | |
| MCD | Medullary cystic disease | |
| MCS | SF-36 Mental Component Summary | |
| MDRD Study | Modification of Diet in Renal Disease Study | |
| MI | Myocardial infarction | |
| Min | Minute(s) | |
| Min | Minimum | |
| MNT | Medical nutrition therapy | |
| Mo | Month(s) | |
| MR | Magnetic resonance | |
| MRI | Magnetic resonance imaging | |
| MSP | Multidimensional Scale of Perceived Social Support | |
| N | Number of subjects in subgroup | |
| N | Number of subjects in sample or population | |
| NA | Not applicable | |
| NAE | Normal urinary albumin excretion | |
| NAG | N-acetyl-<beta>-D-glucosaminidase | |
| NCEP | National Cholesterol Education Program | |
| NCHS | National Center for Health Statistics | |
| NCV | Nerve conduction velocity | |
| ND | No data | |
| NHANES III | Third National Health and Nutrition Examination Survey | |
| NIDDM | Non-insulin dependent diabetes mellitus | |
| NIH | National Institutes of Health | |
| NK | Natural killer | |
| NKF | National Kidney Foundation | |
| No. | Number | |
| NPNA | Normalized protein nitrogen appearance | |
| NS | Non-significant | |
| NSAID | Non-steroidal anti-inflammatory drug | |
| PARADE | Proteinuria, Albuminuria, Risk Assessment, Detection, and Elimination | |
| PCr | Plasma or serum creatinine concentration | |
| PCS | SF-36 Physical Component Summary | |
| PD | Peritoneal dialysis | |
| PEM | Protein-energy malnutrition | |
| PICP | Procollagen type I carboxy-terminal propeptides | |
| Pin | Plasma inulin | |
| PKD | Polycystic kidney disease | |
| PN | Pyelonephritis | |
| PNA | Protein equivalent of total nitrogen appearance | |
| PTH | Parathyroid hormone | |
| PVD | Peripheral vascular disease | |
| QST | Quantitative sensory testing | |
| QWB | Quality of Well-being Scale | |
| RBC | Red blood cell | |
| RBP | Retinol binding protein | |
| RDA | Recommended dietary allowance | |
| RENAAL | Reduction of Endpoints in Non-Insulin Dependent Diabetes Mellitus with the Angiotensin II Antagonist Losartan |
|
| RHIE | Rand Health Insurance Experiment | |
| RPA | Renal Physicians Association | |
| RR | Relative risk | |
| SAS-SR | Social Adjustment Scale Self-Report | |
| SBP | Systolic blood pressure | |
| SBW | Standard body weight | |
| SCL 90R | Symptom Checklist-90RÍ | |
| SCr | Serum creatinine concentration | |
| SD | Standard deviation | |
| SDS-PAGE | Sodium dodecyl sulfate-polyacrylamide gel electrophoresis | |
| SE | Standard error | |
| SF-36 | RAND Medical Outcomes Study 36-Item Health Survey | |
| SGA | Subjective global assessment | |
| SIP | Sickness Impact Profile | |
| SLE | Systemic lupus erythematosus | |
| SLS | Satisfaction with Life Scale | |
| SMBG | Self-monitoring of blood glucose | |
| Sn | Sensitivity | |
| Sp | Specificity | |
| STAI | State Trait Anxiety Inventory | |
| SUN | Serum urea nitrogen | |
| TOD | Target organ damage | |
| TSCr | Tubular creatinine secretion rate | |
| UAC | Urine albumin concentration | |
| UAlb/Cr | Urine albumin-to-creatinine ratio | |
| UCr | Urine creatinine concentration | |
| Uin | Urine inulin concentration | |
| UKPDS | United Kingdom Prospective Diabetes Study | |
| UNA | Urea nitrogen appearance | |
| US | United States | |
| USRDS | United States Renal Data System | |
| UUN | Urine urea nitrogen | |
| V | Urine flow rate | |
| VUrea | Volume of distribution of urea | |
| WBC | White blood cell | |
| WHO | World Health Organization | |
| Wk | Week(s) | |
| Yr | Year(s) | |
| ß-2-MG | ß-2-Microglobulin | |
|
|
Difference/change |
© 2002 National Kidney Foundation, Inc |
